Global B Cell Maturation Antigen (bcma) Market Research Report 2021-2026
December 23, 2021 ⚊ 1 Min read ⚊ Views 210 ⚊ TECH
Over a period of time, the cancer research has deviated for conventional approach and is directed towards the development of novel drugs that selectively targets the oncogenes, thereby reducing the adverse side effects. Genomic analysis have shown that B-cell maturation antigen or CD269 is restrictively expressed in both normal as well as malignant cells at high levels, thus making it an ideal target antigen for development of novel multiple myeloma therapies. BCMA is a member of tumor necrosis factor family and has critical role in the regulating B-cell proliferation and survival.
Tags: b cell maturation antigen market research report, life sciences industry report
